Can-Fite BioPharma (CANF)
NYSE MKT:CANF
Holding CANF?
Track your performance easily

Can-Fite BioPharma (CANF) Financial Statements

495 Followers

Can-Fite BioPharma Financial Overview

Can-Fite BioPharma's market cap is currently ―. The company's EPS TTM is $-1.857; its P/E ratio is -1.16; Can-Fite BioPharma is scheduled to report earnings on November 29, 2024, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue--$ 204.00K$ 204.00K$ 205.00K
Gross Profit-----
EBIT--$ -2.57M$ -2.07M$ -2.37M
EBITDA--$ -2.57M$ -2.07M$ -2.37M
Net Income Common Stockholders--$ -2.53M$ -2.19M$ -2.43M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 8.92M$ 7.99M$ 10.81M$ 12.77M$ 16.70M
Total Assets$ 9.99M$ 9.28M$ 12.71M$ 14.75M$ 17.85M
Total Debt$ 40.00K$ 62.00K$ 74.00K$ 87.00K$ 109.00K
Net Debt$ -8.88M$ -7.92M$ -10.74M$ -12.68M$ -16.59M
Total Liabilities$ 3.75M$ 4.81M$ 5.28M$ 4.85M$ 5.82M
Stockholders Equity$ 6.24M$ 4.47M$ 7.43M$ 9.89M$ 12.02M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

Can-Fite BioPharma Earnings and Revenue History

Can-Fite BioPharma Debt to Assets

Can-Fite BioPharma Cash Flow

Can-Fite BioPharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis